These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15806175)

  • 1. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
    Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
    Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
    Murphy KM; Brune KA; Griffin C; Sollenberger JE; Petersen GM; Bansal R; Hruban RH; Kern SE
    Cancer Res; 2002 Jul; 62(13):3789-93. PubMed ID: 12097290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
    Cho JH; Bang S; Park SW; Chung JB; Song SY
    Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
    Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
    Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
    Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.
    Obazee O; Archibugi L; Andriulli A; Soucek P; Małecka-Panas E; Ivanauskas A; Johnson T; Gazouli M; Pausch T; Lawlor RT; Cavestro GM; Milanetto AC; Di Leo M; Pasquali C; Hegyi P; Szentesi A; Radu CE; Gheorghe C; Theodoropoulos GE; Bergmann F; Brenner H; Vodickova L; Katzke V; Campa D; Strobel O; Kaiser J; Pezzilli R; Federici F; Mohelnikova-Duchonova B; Boggi U; Lemstrova R; Johansen JS; Bojesen SE; Chen I; Jensen BV; Capurso G; Pazienza V; Dervenis C; Sperti C; Mambrini A; Hackert T; Kaaks R; Basso D; Talar-Wojnarowska R; Maiello E; Izbicki JR; Cuk K; Saum KU; Cantore M; Kupcinskas J; Palmieri O; Delle Fave G; Landi S; Salvia R; Fogar P; Vashist YK; Scarpa A; Vodicka P; Tjaden C; Iskierka-Jazdzewska E; Canzian F
    Int J Cancer; 2019 Aug; 145(3):686-693. PubMed ID: 30672594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
    Wheatley-Price P; Asomaning K; Reid A; Zhai R; Su L; Zhou W; Zhu A; Ryan DP; Christiani DC; Liu G
    Cancer; 2008 Mar; 112(5):1037-42. PubMed ID: 18205184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
    Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature.
    Ghataorhe P; Kurian AW; Pickart A; Trapane P; Norton JA; Kingham K; Ford JM
    Cancer Genet Cytogenet; 2007 Dec; 179(2):89-92. PubMed ID: 18036394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.
    Akbari MR; Malekzadeh R; Nasrollahzadeh D; Amanian D; Islami F; Li S; Zandvakili I; Shakeri R; Sotoudeh M; Aghcheli K; Salahi R; Pourshams A; Semnani S; Boffetta P; Dawsey SM; Ghadirian P; Narod SA
    Oncogene; 2008 Feb; 27(9):1290-6. PubMed ID: 17724471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer.
    Kristiansen M; Knudsen GP; Maguire P; Margolin S; Pedersen J; Lindblom A; Ørstavik KH
    J Med Genet; 2005 Nov; 42(11):877-80. PubMed ID: 15879497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
    Li D; Ahmed M; Li Y; Jiao L; Chou TH; Wolff RA; Lenzi R; Evans DB; Bondy ML; Pisters PW; Abbruzzese JL; Hassan MM
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1470-6. PubMed ID: 15941958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The estrogen receptor alpha C975G variant in familial and sporadic breast cancer: a case-control study.
    Skoglund J; Margolin S; Zhou XL; Maguire P; Werelius B; Lindblom A
    Anticancer Res; 2006; 26(4B):3077-81. PubMed ID: 16886637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with earlier age of onset in familial pancreatic carcinoma.
    James TA; Sheldon DG; Rajput A; Kuvshinoff BW; Javle MM; Nava HR; Smith JL; Gibbs JF
    Cancer; 2004 Dec; 101(12):2722-6. PubMed ID: 15534880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
    Meeks HD; Song H; Michailidou K; Bolla MK; Dennis J; Wang Q; Barrowdale D; Frost D; ; McGuffog L; Ellis S; Feng B; Buys SS; Hopper JL; Southey MC; Tesoriero A; ; James PA; Bruinsma F; Campbell IG; ; Broeks A; Schmidt MK; Hogervorst FB; ; Beckman MW; Fasching PA; Fletcher O; Johnson N; Sawyer EJ; Riboli E; Banerjee S; Menon U; Tomlinson I; Burwinkel B; Hamann U; Marme F; Rudolph A; Janavicius R; Tihomirova L; Tung N; Garber J; Cramer D; Terry KL; Poole EM; Tworoger SS; Dorfling CM; van Rensburg EJ; Godwin AK; Guénel P; Truong T; ; Stoppa-Lyonnet D; Damiola F; Mazoyer S; Sinilnikova OM; Isaacs C; Maugard C; Bojesen SE; Flyger H; Gerdes AM; Hansen TV; Jensen A; Kjaer SK; Hogdall C; Hogdall E; Pedersen IS; Thomassen M; Benitez J; González-Neira A; Osorio A; Hoya Mde L; Segura PP; Diez O; Lazaro C; Brunet J; Anton-Culver H; Eunjung L; John EM; Neuhausen SL; Ding YC; Castillo D; Weitzel JN; Ganz PA; Nussbaum RL; Chan SB; Karlan BY; Lester J; Wu A; Gayther S; Ramus SJ; Sieh W; Whittermore AS; Monteiro AN; Phelan CM; Terry MB; Piedmonte M; Offit K; Robson M; Levine D; Moysich KB; Cannioto R; Olson SH; Daly MB; Nathanson KL; Domchek SM; Lu KH; Liang D; Hildebrant MA; Ness R; Modugno F; Pearce L; Goodman MT; Thompson PJ; Brenner H; Butterbach K; Meindl A; Hahnen E; Wappenschmidt B; Brauch H; Brüning T; Blomqvist C; Khan S; Nevanlinna H; Pelttari LM; Aittomäki K; Butzow R; Bogdanova NV; Dörk T; Lindblom A; Margolin S; Rantala J; Kosma VM; Mannermaa A; Lambrechts D; Neven P; Claes KB; Maerken TV; Chang-Claude J; Flesch-Janys D; Heitz F; Varon-Mateeva R; Peterlongo P; Radice P; Viel A; Barile M; Peissel B; Manoukian S; Montagna M; Oliani C; Peixoto A; Teixeira MR; Collavoli A; Hallberg E; Olson JE; Goode EL; Hart SN; Shimelis H; Cunningham JM; Giles GG; Milne RL; Healey S; Tucker K; Haiman CA; Henderson BE; Goldberg MS; Tischkowitz M; Simard J; Soucy P; Eccles DM; Le N; Borresen-Dale AL; Kristensen V; Salvesen HB; Bjorge L; Bandera EV; Risch H; Zheng W; Beeghly-Fadiel A; Cai H; Pylkäs K; Tollenaar RA; Ouweland AM; Andrulis IL; Knight JA; ; Narod S; Devilee P; Winqvist R; Figueroa J; Greene MH; Mai PL; Loud JT; García-Closas M; Schoemaker MJ; Czene K; Darabi H; McNeish I; Siddiquil N; Glasspool R; Kwong A; Park SK; Teo SH; Yoon SY; Matsuo K; Hosono S; Woo YL; Gao YT; Foretova L; Singer CF; Rappaport-Feurhauser C; Friedman E; Laitman Y; Rennert G; Imyanitov EN; Hulick PJ; Olopade OI; Senter L; Olah E; Doherty JA; Schildkraut J; Koppert LB; Kiemeney LA; Massuger LF; Cook LS; Pejovic T; Li J; Borg A; Öfverholm A; Rossing MA; Wentzensen N; Henriksson K; Cox A; Cross SS; Pasini BJ; Shah M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Gronwald J; Agnarsson BA; Kupryjanczyk J; Moes-Sosnowska J; Fostira F; Konstantopoulou I; Slager S; Jones M; ; Antoniou AC; Berchuck A; Swerdlow A; Chenevix-Trench G; Dunning AM; Pharoah PD; Hall P; Easton DF; Couch FJ; Spurdle AB; Goldgar DE
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26586665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial pancreatic cancer syndromes.
    Habbe N; Langer P; Sina-Frey M; Bartsch DK
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.